Phase I/Ib Study of Olaparib and Carboplatin in BRCA1 or BRCA2 Mutation-Associated Breast or Ovarian Cancer With Biomarker Analyses JM Lee, JL Hays, CM Annunziata, AM Noonan, L Minasian, JA Zujewski, ... Journal of the National Cancer Institute 106 (6), dju089, 2014 | 220 | 2014 |
Randomized phase 2 trial of the oncolytic virus pelareorep (Reolysin) in upfront treatment of metastatic pancreatic adenocarcinoma AM Noonan, MR Farren, SM Geyer, Y Huang, S Tahiri, D Ahn, S Mikhail, ... Molecular Therapy 24 (6), 1150-1158, 2016 | 146 | 2016 |
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma C Akateh, SM Black, L Conteh, ED Miller, A Noonan, E Elliott, TM Pawlik, ... World journal of gastroenterology 25 (28), 3704, 2019 | 131 | 2019 |
Characterization of ovarian cancer cell lines as in vivo models for preclinical studies L Hernandez, MK Kim, LT Lyle, KP Bunch, CD House, F Ning, ... Gynecologic oncology 142 (2), 332-340, 2016 | 114 | 2016 |
Systemic immune activity predicts overall survival in treatment-naive patients with metastatic pancreatic cancer MR Farren, TA Mace, S Geyer, S Mikhail, C Wu, K Ciombor, S Tahiri, ... Clinical cancer research 22 (10), 2565-2574, 2016 | 101 | 2016 |
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum‐resistant or‐refractory epithelial ovarian cancer AM Noonan, KP Bunch, JQ Chen, MA Herrmann, JM Lee, EC Kohn, ... Cancer 122 (4), 588-597, 2016 | 90 | 2016 |
Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). MJ Overman, P LoRusso, JH Strickler, SP Patel, SJ Clarke, AM Noonan, ... Journal of Clinical Oncology 36 (15_suppl), 4123-4123, 2018 | 78 | 2018 |
Immune checkpoint inhibitors in hepatocellular cancer: current understanding on mechanisms of resistance and biomarkers of response to treatment AE Onuma, H Zhang, H Huang, TM Williams, A Noonan, A Tsung Gene expression 20 (1), 53, 2020 | 77 | 2020 |
A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer. S Shahda, AM Noonan, TS Bekaii-Saab, BH O'Neil, A Sehdev, WL Shaib, ... Journal of Clinical Oncology 35 (15_suppl), 3541-3541, 2017 | 76 | 2017 |
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. KEC Moon DH, Lee JM, Noonan AM, Annunziata CM British Journal of Cancer 109 (4), 1072-8, 2013 | 75 | 2013 |
CD200 promotes immunosuppression in the pancreatic tumor microenvironment F Choueiry, M Torok, R Shakya, K Agrawal, A Deems, B Benner, A Hinton, ... Journal for immunotherapy of cancer 8 (1), 2020 | 71 | 2020 |
Randomized phase II study of pet response–adapted combined modality therapy for esophageal cancer: mature results of the CALGB 80803 (Alliance) trial KA Goodman, FS Ou, NC Hall, T Bekaii-Saab, B Fruth, E Twohy, ... Journal of Clinical Oncology 39 (25), 2803, 2021 | 68 | 2021 |
IKK-epsilon coordinates invasion and metastases of ovarian cancer ACM Hsu S, Kim M, Hernandez L, Grajales V, Noonan A Cancer Research 72 (21), 5494-504, 2012 | 62* | 2012 |
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers M Yarchoan, L Cope, AN Ruggieri, RA Anders, AM Noonan, LW Goff, ... The Journal of Clinical Investigation 131 (24), 2021 | 55 | 2021 |
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in mice KM Huang, AF Leblanc, ME Uddin, JY Kim, M Chen, ED Eisenmann, ... The Journal of clinical investigation 130 (9), 4601-4606, 2020 | 54 | 2020 |
Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance DH Ahn, M Javle, CW Ahn, A Jain, S Mikhail, AM Noonan, C Wu, ... Cancer 122 (23), 3657-3666, 2016 | 52 | 2016 |
Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel AM Noonan, RA Eisch, DJ Liewehr, TM Sissung, DJ Venzon, TP Flagg, ... Clinical Cancer Research 19 (11), 3095-3104, 2013 | 49 | 2013 |
Implementing a multidisciplinary approach for older adults with cancer: geriatric oncology in practice CJ Presley, JL Krok-Schoen, SA Wall, AM Noonan, DC Jones, E Folefac, ... Bmc Geriatrics 20, 1-9, 2020 | 47 | 2020 |
Adjuvant nab-paclitaxel+ gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ... Journal of Clinical Oncology 41 (11), 2007, 2023 | 46 | 2023 |
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis DH Ahn, K Krishna, M Blazer, J Reardon, L Wei, C Wu, KK Ciombor, ... Therapeutic Advances in Medical Oncology 9 (2), 75-82, 2017 | 45 | 2017 |